Breaking Barriers in Pain Management and ADHD Treatment with Tris Pharma James Hackworth

In this episode of the Lifescience Success Podcast, host Don Davis interviews James Hackworth, who shares insights about his background in physics and his journey into the life science industry. James discusses his experiences from McKinsey up to his current role at Tris Pharma, focusing on their innovative drug development and formulation technologies. He dives into the company's advancements in ADHD medications and an exciting new pain management drugs. Additionally, the conversation highlights the importance of partnerships, technology in drug development, and future industry trends. James provides a fascinating glimpse into the complexities and future of pharmaceuticals.

00:00 Welcome and Introduction
00:08 Impressions of the Bio Conference
00:42 James' Background and Journey into Pharma
03:17 Formation and Growth of Park Therapeutics
04:20 Overview of Tris Pharma
04:41 Tris Pharma's Focus and Innovations
08:00 Challenges and Opportunities in Partnering
10:58 Future of Tris Pharma and the Industry
15:41 In-depth Look at Drugs that are progressing
19:21 Conclusion and Final Thoughts